Ana Rita Santos: Cost-Effectiveness of Chatbot-Supported Remote Monitoring for Anticoagulation Management
Ana Rita Santos, Visiting Researcher at Uppsala Health Economics, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in JMIR Publications, adding:
“I am delighted to share that my second PhD paper has now been published in the JMIR Publications.
This study evaluates the cost-effectiveness of a chatbot-supported remote patient monitoring intervention for anticoagulation management, contributing to the evidence on the economic evaluation of digital health technologies.
A special thank you to my co-authors: Filipa Sampaio, Federico Guede Fernández, Julian Perelman, and Ana Rita Londral.”
Title: Cost-Effectiveness Analysis of Chatbot-Supported Remote Patient Monitoring for Anticoagulation Management: Health Economic Evaluation Within a Pilot Crossover Trial
Authors: Ana Rita Santos, Filipa Sampaio, Federico Guede-Fernández, Julian Perelman, Ana Londral.
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 18, 2026, 19:46Angela Fan: Highlighting the Significant Burden Faced by Patients Living With PV
-
Jun 18, 2026, 15:29Santagata Davide: Timely Removal of Retrievable IVC Filters May Reduce VTE Recurrence and Mortality
-
Jun 18, 2026, 15:13Youssef Afifi: The Thrombocytosis–Bleeding Paradox
-
Jun 18, 2026, 15:06Nihala Sharin E A: The Vital Role of Hematology in the Medical Laboratory
-
Jun 18, 2026, 14:59Maeve Crowley: Shining a Light on Venous Thromboembolism Trends in Ireland
-
Jun 18, 2026, 14:52Samwel Mikaye: Why Early Recognition of Pulmonary Embolism Matters
-
Jun 18, 2026, 14:34Alec van Gelder: From Crisis Care to Continuous Care in SCD
-
Jun 18, 2026, 14:33Zahabia Adnan: Meta-Analysis Supports Rivaroxaban as an Effective Option for Cancer-Associated VTE
-
Jun 18, 2026, 14:17Charlotte Aubin: A New Perspective on BDNF’s Influence on Hemostasis and Thrombotic Risk